These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25196534)

  • 21. Detection of synthetic cannabinoids in herbal incense products.
    Penn HJ; Langman LJ; Unold D; Shields J; Nichols JH
    Clin Biochem; 2011 Sep; 44(13):1163-1165. PubMed ID: 21741374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?
    Fantegrossi WE; Moran JH; Radominska-Pandya A; Prather PL
    Life Sci; 2014 Feb; 97(1):45-54. PubMed ID: 24084047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence and properties of spice and bath salts: a medicinal chemistry perspective.
    Lewin AH; Seltzman HH; Carroll FI; Mascarella SW; Reddy PA
    Life Sci; 2014 Feb; 97(1):9-19. PubMed ID: 24113072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic Cannabinoids.
    Mills B; Yepes A; Nugent K
    Am J Med Sci; 2015 Jul; 350(1):59-62. PubMed ID: 26132518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly sensitive screening and analytical characterization of synthetic cannabinoids in nine different herbal mixtures.
    Alves VL; Gonçalves JL; Aguiar J; Caldeira MJ; Teixeira HM; Câmara JS
    Anal Bioanal Chem; 2021 Mar; 413(8):2257-2273. PubMed ID: 33575815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. K2--not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report.
    McKeever RG; Vearrier D; Jacobs D; LaSala G; Okaneku J; Greenberg MI
    J Med Toxicol; 2015 Mar; 11(1):129-31. PubMed ID: 25154434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Designer drugs. Patients may be using synthetic cannabinoids more than you think.
    Lisi DM
    JEMS; 2014 Sep; 39(9):56-9. PubMed ID: 25322519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Searching for truth: internet search patterns as a method of investigating online responses to a Russian illicit drug policy debate.
    Zheluk A; Gillespie JA; Quinn C
    J Med Internet Res; 2012 Dec; 14(6):e165. PubMed ID: 23238600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.
    Gurdal F; Asirdizer M; Aker RG; Korkut S; Gocer Y; Kucukibrahimoglu EE; Ince CH
    J Forensic Leg Med; 2013 Aug; 20(6):667-72. PubMed ID: 23910858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Synthetic cannabinoids--the new "legal high" drugs].
    Berkovitz R; Arieli M; Marom E
    Harefuah; 2011 Dec; 150(12):884-7, 937. PubMed ID: 22352277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in 'Spice'.
    Dargan PI; Hudson S; Ramsey J; Wood DM
    Int J Drug Policy; 2011 Jul; 22(4):274-7. PubMed ID: 21482092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review.
    Alves VL; Gonçalves JL; Aguiar J; Teixeira HM; Câmara JS
    Crit Rev Toxicol; 2020 May; 50(5):359-382. PubMed ID: 32530350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Spice in France: mixed herbs containing synthetic cannabinoids].
    Schlatter J; Chiadmi F; Chariot P
    Ann Biol Clin (Paris); 2012; 70(4):413-22. PubMed ID: 22796613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong.
    Tung CK; Chiang TP; Lam M
    East Asian Arch Psychiatry; 2012 Mar; 22(1):31-3. PubMed ID: 22447803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spice/K2 drugs--more than innocent substitutes for marijuana.
    Zawilska JB; Wojcieszak J
    Int J Neuropsychopharmacol; 2014 Mar; 17(3):509-25. PubMed ID: 24169044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The illegal synthetic cannabinoid drug market in Israel - evolution and new challenges].
    Shapira B; Poperno A; Berkovitz R
    Harefuah; 2016 Sep; 155(9):526-530. PubMed ID: 28530077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurotoxicity of Synthetic Cannabinoids JWH-081 and JWH-210.
    Cha HJ; Seong YH; Song MJ; Jeong HS; Shin J; Yun J; Han K; Kim YH; Kang H; Kim HS
    Biomol Ther (Seoul); 2015 Nov; 23(6):597-603. PubMed ID: 26535086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial infarction associated with use of the synthetic cannabinoid K2.
    Mir A; Obafemi A; Young A; Kane C
    Pediatrics; 2011 Dec; 128(6):e1622-7. PubMed ID: 22065271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of the novel synthetic cannabimimetic 8-quinolinyl 4-methyl-3-(1-piperidinylsulfonyl)benzoate (QMPSB) and other designer drugs in herbal incense.
    Blakey K; Boyd S; Atkinson S; Wolf J; Slottje PM; Goodchild K; McGowan J
    Forensic Sci Int; 2016 Mar; 260():40-53. PubMed ID: 26795397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure.
    Gudsoorkar VS; Perez JA
    Methodist Debakey Cardiovasc J; 2015; 11(3):189-91. PubMed ID: 26634029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.